Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer.
Wolden, S L
Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer. [electronic resource] - International journal of radiation oncology, biology, physics Mar 2000 - 859-64 p. digital
Publication Type: Journal Article
0360-3016
10.1016/s0360-3016(99)00493-9 doi
Adolescent
Adult
Antineoplastic Agents--adverse effects
Carcinoma--drug therapy
Carcinoma, Squamous Cell--drug therapy
Child
Cisplatin--adverse effects
Combined Modality Therapy
Disease-Free Survival
Female
Follow-Up Studies
Humans
Male
Nasopharyngeal Neoplasms--drug therapy
Neoplasms, Second Primary--etiology
Radiotherapy--adverse effects
Radiotherapy Dosage
Retrospective Studies
Survival Rate
Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer. [electronic resource] - International journal of radiation oncology, biology, physics Mar 2000 - 859-64 p. digital
Publication Type: Journal Article
0360-3016
10.1016/s0360-3016(99)00493-9 doi
Adolescent
Adult
Antineoplastic Agents--adverse effects
Carcinoma--drug therapy
Carcinoma, Squamous Cell--drug therapy
Child
Cisplatin--adverse effects
Combined Modality Therapy
Disease-Free Survival
Female
Follow-Up Studies
Humans
Male
Nasopharyngeal Neoplasms--drug therapy
Neoplasms, Second Primary--etiology
Radiotherapy--adverse effects
Radiotherapy Dosage
Retrospective Studies
Survival Rate